Opportunities Assessment for Diabetes Therapeutics Market-Taiwan
Opportunities Assessment for Diabetes Therapeutics Market-Taiwan
RELEASE DATE
19-Dec-2008
19-Dec-2008
REGION
Asia Pacific
Asia Pacific
Research Code: P1FE-01-00-00-00
SKU: HC02256-AP-MR_08109
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02256-AP-MR_08109
Description
This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Taiwan.
Table of Contents
Overview
- Executive Summary
Market Overview
- Introduction
- Context for the Study
- Research Service Scope and Segmentation
- Methodology
- Restraints in Forecasts
Market Overview
- Introduction
- Market Engineering Measurements
- Government Initiatives
- Listing Drugs Under the Government Reimbursement Plan
Market Forecasts and Trends
- Patient Forecasts
- Cost of Treatment
Treatment and Diagnosis
- Key Treaters
- Diagnostic Tests
- Treatment Options
- Treatment Practice and Glycemic Control
- Use of Insulin
- Key Factors/Drivers to Prescribe Insulin
- Duration of Treatment
- Product Share by Endocrinologists and GPS
- Product/Class Launches in 2007 and in future
- Clinical Trials
Competitive Analysis
- Competitive Structure
- Market Share Analysis
- Future Trends
- Challenges Faced by Physicians
Popular Topics
This research service aims to provide an update on the epidemiology of T2 diabetes, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Taiwan.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | P1FE-01-00-00-00 |
Is Prebook | No |